The QualityStocks Daily Thursday, August 23rd, 2018

Today's Top 3 StockMarketWatch

QualityStocks (SKVI) +50.54%

WallstreetSurfers (SSOK) +47.86%

MarketBeat (NOBGY) +43.23%

The QualityStocks Daily Stock List

American Power Group Corp. (APGI)

Marketbeat.com, Stock News Now, and SmallCapVoice reported on American Power Group Corp. (APGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

American Power Group Corp. designs and produces proven alternative fuel solutions for stationary power generators, backup power systems, and commercial transportation. The Company’s alternative energy subsidiary, American Power Group, Inc. (APG), provides a cost-effective patented Turbocharged Natural Gas® Dual Fuel Conversion Technology for vehicular, stationary, as well as off-road mobile diesel engines. American Power Group is headquartered in Lynnfield, Massachusetts and lists on the OTC Markets Group’s OTCQB.

The Company’s patented Turbocharged Natural Gas® Dual Fuel Conversion Technology is a unique non-invasive software driven solution. It converts existing vehicular and stationary diesel engines to run simultaneously on diesel and different kinds of natural gas. This includes compressed natural gas, liquefied natural gas, conditioned well-head/ditch gas or bio-methane gas with the flexibility to return to 100 percent diesel fuel operation at any time.  It is a ground-breaking non-invasive energy enhancement system.

American Power Group (with its proprietary Flare to Fuel™ process technology) can convert captured gases into natural gas liquids (NGLs) that can sell as heating fluids, emulsifiers, or be further processed by refiners. Via the Company’s Trident Associated Gas Capture and Recovery Technology, it can provide oil and gas producers a flare capture service solution for associated gases produced at their remote and stranded well sites.  

Regarding American Power Group’s dual fuel, methane gas is metered into a diesel engine's air intake, before the turbocharger, by the air filter. As the enriched air/gas mixture increases the engine's power, the diesel's own governor senses the power increase and backs off on diesel flow. The system maintains a balance of gas-to-diesel ratios.

The maintaining of the energized fuel balance is with a proprietary read-only electronic controller system. This ensures the engines operate at original equipment manufacturers' (OEMs) specified temperatures and pressures. Installation on a broad collection of engine models and end-market applications demands no engine modifications.

Yesterday, American Power Group announced that it will extend the filing of its June 30, 2017 Quarterly Form 10Q through SEC Form 12b-25. The Company announced on June 6, 2017, a corporate wide realignment of its strategic direction, reallocation of resources, and reduction in workforce in response to considerable operating losses because of the effect that ongoing low oil prices were having on its dual fuel and flare capture businesses. The realignment resulted in a decrease in annual operating costs of greater than $2 million on a going forward basis.

American Power Group Corp. (APGI), closed Thursday's trading session at $0.05, up 11.11%, on 175,657 volume with 5 trades. The average volume for the last 60 days is 84,915 and the stock's 52-week low/high is $0.0023/$0.1195.

chart

Solis Tek, Inc. (SLTK)

Penny Stock Tweets, Zacks, Real Investment Advice, InvestorsHub, Wallet Investor, Market Exclusive, Stockhouse, Trading View and MarketWatch reported on Solis Tek, Inc. (SLTK), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Solis Tek, Inc. is a vertically integrated cannabis technology innovator, developer, manufacturer, and distributor. The Company’s focus is on bringing products and solutions to commercial cannabis growers in legal markets throughout the U.S. Solis Tek’s emphasis is on the research, design, development, and manufacturing of advanced and efficient lighting products. OTCQB-listed, the Company is based in Carson, California.

Solis Tek has acquired YLK Partners NV, LLC.  YLK is an Arizona-based company, which has in place a management services agreement to provide turn-key services for the management, administration, and operation of a licensed medical marijuana cultivation and processing facility undergoing development by the holder of a Medical Marijuana Dispensary Registration Certificate issued by the Arizona Department of Health Services (Arizona Licensee).

Solis Tek’s technology includes Ignition Control; SenseSmart™, and the industry’s lowest output THD (Total Harmonic Distortion) percent. The Company states that its ballasts offer the industry's only true Ignition Control staggered ignition technology. Its sequential lamp ignition technology will ignite lamps one at a time based on load stability.

Solis Tek’s product categories include complete systems; digital ballasts, DE Lamps; SE Lamps; CMH Lamps; Reflectors; and accessories. Its customers include retail stores, distributors, and commercial growers in the U.S. and worldwide.

The Company’s SenseSmart™ will check for eight different factors before attempting to power the lamp. The intention of this is increased user safety. SenseSmart™ checks for open output; high/low temperatures; ignition failure; thermal; end of lamp life; overflow current; over/low voltage; and short circuit.

Solis Tek has its Nutrient Line. This Line uses natural ingredients to help growers increase yield, reduce costs, and ultimately grow healthier plants. This is an element of the Company’s overall strategy to provide a broad group of products and services targeted at the commercial cannabis industry.

Terpenez™ is the first product in the Nutrient Line. This product is an organically derived, commercial grade essential oil intensifier blended in California. The design of it is to naturally increase the terpene profile of the cannabis plant and enhance the aromatic experience associated with gardening. In addition, the Company offers its lighting controller. It enables commercial growers to harness more control of their gardens lighting environment.

Solis Tek’s Board of Directors and Company Management are rebranding the corporate entity and public company name to better reflect management’s strategy to transition to high growth opportunities in legalized cannabis jurisdictions. This includes cultivation and processing. Solis Tek will continue to develop and innovate its lighting division as Solis Tek Digital Lighting and its nutrients division as Zelda Horticulture.

Solis Tek’s newly acquired cultivation and processing facility, now under build-out construction, is expected to become revenue generating in Q2 2019. The 70,000-square foot facility is operating under a current Arizona licensee with Solis Tek having complete operational, management and sales control. Production and oil extraction are in the process of build-out with equipment to be acquired in Q3 of 2018.

Solis Tek, Inc. (SLTK), closed Thursday's trading session at $0.825, up 11.49%, on 354,992 volume with 251 trades. The average volume for the last 60 days is 70,247 and the stock's 52-week low/high is $0.40/$2.64.

chart

Freedom Leaf, Inc. (FRLF)

MicroSmallCap, Promotion Stock Secrets, Daily Marijuana Observer, OTC Markets, Stockhouse, InvestorsHub, CFN Media Group, SmallCapVoice, Penny Stock Tweets, and StocksToBuyNow reported on Freedom Leaf, Inc. (FRLF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Freedom Leaf, Inc. (The Marijuana Legalization Company™) is a group of international, vertically integrated hemp businesses and cannabis media companies. It is a leading go-to resource in the cannabis, medical marijuana, and industrial hemp industry. Freedom Leaf is building a diverse portfolio of valuable businesses through strategic mergers, acquisitions, and acceleration projects across the industry. Freedom Leaf has its corporate office in Las Vegas, Nevada. Leafceuticals, Inc. is a wholly-owned division of Freedom Leaf.

Freedom Leaf does not handle, grow, sell, or disperse marijuana. The Company targets acquisitions of high growth and niche companies. Its strategy is to identify select technology companies and companies that are involved in cannabis and industrial hemp genetics, intellectual property (IP), bioscience, nutraceutical, and pharmaceutical product development.

Its flagship publication is Freedom Leaf Magazine, The Good News in Marijuana Reform. Freedom Leaf produces a portfolio of news, print, and digital multi-media verticals, websites, and web advertising, for the ever-developing and changing cannabis, medical marijuana, and industrial hemp industry.

Freedom Leaf has its LaMarihuana.com. This is the Spanish Speaking community's top cannabis website. Freedom Leaf also has its www.Marihuana-Medicinal.com. This is the largest Medical Cannabis information portal in Spanish.

Hempology® is the Company’s exclusively branded product line. Hempology® is now vertically integrated from seed to consumer, processing CBD and a whole spectrum of whole-hemp extracts for the entourage-effect. Freedom Leaf also has its hemp-based rolling paper company, Plants to Paper.

Freedom Leaf has acquired 100 percent of Green Market Europe S.L. (GME). GME is a Spanish producer of hemp products. Freedom Leaf announced this past April that it consummated its previously announced acquisition of the Irie CBD Product Line. This includes virtually all assets, trademarks, formulating equipment, formulas and products. Irie is a California-based CBD, "Cannabidiol", product line.

At the beginning of August, Freedom Leaf announced that it consummated a 100 percent acquisition of Tierra Science Global, LLC. Tierra specializes in health supplements supporting peak bio-energy levels in humans. These are presently distributed by way of direct sales teams and well established affiliate programs in the U.S., Europe and Asia.

Freedom Leaf, Inc. (FRLF), closed Thursday's trading session at $0.169, down 1.74%, on 762,878 volume with 135 trades. The average volume for the last 60 days is 523,984 and the stock's 52-week low/high is $0.0265/$0.4719.

chart

Flux Power Holdings, Inc. (FLUX)

StockMister, The Wall Street Transcript, Stock News Now, PennyStocks24, Tip.us, Catalyst IR, Joe Penny Stocks, Liquid Tycoon, Super Hot Penny Stocks, Super Nova Stock Picks, WePickPennyStocks, Winning Penny Stock Picks, Penny Stock Pick Alert, Penny Stock Pick Report, PennyPickAlerts, PennyStockMoneyTrain, RisingPennyStocks, Lebed, Wall Street Grand, and Greenbackers reported previously on Flux Power Holdings, Inc. (FLUX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Flux Power Holdings, Inc. is a developer of advanced lithium batteries for industrial applications. This includes its first-ever UL 2271 Listed lithium-ion "LiFT Pack" forklift batteries. The Company develops and markets advanced lithium-ion energy storage systems (batteries) based on its proprietary battery management system (BMS) and in-house engineering and product design. Flux Power Holdings has its corporate office in Vista, California.

The Company’s storage solutions deliver improved performance, extended cycle life, and greater return on investment (ROI) than legacy solutions. Its products include advanced battery packs for motive power in the lift equipment, tug and tow, and robotics markets, portable power for military applications, and stationary power for grid storage.

Applications include Motive Power, Portable Power, and Stationary Power. Motive Power includes Lift Pack - Class III Walkie Trucks and Lift Pack - Tug & Tow Pack.

Regarding Portable Power, Flux Portable Packs consist of lithium-ion battery cells, which are managed and operated by its proprietary Battery Management System (BMS), all contained in lightweight, strong, and easily maneuvered cases.

The design of the Company’s LiFT Pack solution is for walkie pallet jack forklifts, widely used in warehouses and depots, on trucks, and at retail locations. Flux has developed a 72 volt, 400 Ah battery pack to power electric aviation ground support equipment, initially baggage tow tractors utilizing the same proprietary technology found on the LiFT Pack line for small forklifts.

Concerning the Flux battery model: LiFT-24V, it offers up to a 5 times longer lifespan and up to a 25 percent longer run time. Additionally, it offers higher sustained power during every work shift. It is maintenance-free and fewer batteries are needed for multi-shift applications.

Flux recently received a $980,000 purchase order for lithium-ion batteries for airport ground service equipment from a top international airline. The order was secured by the Company’s GSE distribution partner Averest, Inc. following testing over the past year.

Furthermore, Flux is finalizing a Global Master Purchase Agreement with a Fortune 100 customer that completed a successful pilot of Flux’s LiFT Pack for Class 1 counterbalance forklifts and has started the same process for their Class 2 forklifts. Moreover, during FY 2018, Flux delivered its new Class 3 End Rider Lift Pack demonstration units to a handful of customers, OEM’s and equipment dealers. Also, a foremost international beverage company is now piloting Flux’s LiFT Packs for Class 3 walkie forklifts for potential use in certain regional bottling plants in the United States.

Flux Power Holdings, Inc. (FLUX), closed Thursday's trading session at $2.50, up 2.46%, on 9,825 volume with 23 trades. The average volume for the last 60 days is 15,619 and the stock's 52-week low/high is $0.1355/$3.35.

chart

Gopher Protocol, Inc. (GOPH)

OTCtipReporter, PennyStockScholar, Wall Street Mover, Profitable Trader Authority, PennyTrader, and Integrity Solution IR reported earlier on Gopher Protocol, Inc. (GOPH), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Gopher Protocol, Inc. is developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology. A development stage enterprise, Gopher Protocol provides a mobile technology for computing power enhancement, advanced mobile database management/sharing, and additional features. The Company’s Integrated Circuit (IC), which goes by the name GopherInsight™, and accompanied software, creates a private and secured network for sharing information and adapting to user preferences. This system is self-learning and constantly evolving. Listed on the OTCQB, Gopher Protocol is headquartered in Santa Monica, California. 

The Company is developing a real-time, heuristic based, mobile technology. When developed, the mobile technology will consist of a smart microchip, mobile application software and supporting software, which run on a server. The system envisages the creation of a global network.

Gopher Protocol’s belief is that this will be the first system developed utilizing a human, heuristic based analysis engine. The core of this system will be its advanced microchip, which will be able to undergo installation in any mobile device worldwide. Gopher Protocol expects that this will result in an internal, private network between all mobile devices using the device through providing mobile technology for computing power enhancement, advanced mobile database management/sharing, and additional mobile features.

The Company’s licensed technology, the Guardian Patch, could potentially save a person’s life. The new mobile tracking technology will track and protect anything one cares about, with or without GPS (Global Positioning System). The Guardian Patch is an inventive location technology. It is a stick-on tracking device. It protects and tracks everything from a phone to a loved-one or a pet. The Guardian Patch device was conceived as an offshoot of Gopher Protocol’s microchip technology called GopherInsight™.

Gopher Protocol is developing, under exclusive license, mobile, intelligent technology, which connects mobile devices via its private, secured communication protocol. This is to provide advanced features. The Guardian Patch is based on this technology. Each Guardian Patch device is connected to all others through its private, secured protocol. The device is attached onto objects, mobile or static. Upon being attached, it starts its operation as a tracking device.

The Company released a new version of Epsilon (version 2.1.) on June 15, 2017. The creation of Epsilon was to implement improvements in the semiconductor development and design industry, allowing semiconductor manufacturers to accelerate the development process of chips, and provide for the optimization of chip design so that it uses less power.

Recently, Gopher Protocol started research and development (R&D) to modify its existing product offerings of mobile tracking to include a drone tracking security feature. This new feature includes an innovative enhancement, which will enable trigger drone operation through "obeying" a remote order undergoing transmission using the GopherInsight™ radio technology from any remote location.

When this phase of development is complete, the system (hardware & software) will deploy a drone response to a potential crime scene. It may provide law enforcement with real-time video of the scene. The Company bought the domain dronerespond.com and will present its development on this domain. Moreover, Gopher Protocol is preparing to launch Orb Tracker this summer as its initial advanced tracking server designed to provide hardware and software support to Internet of Things (IoT) products.

Gopher Protocol, Inc. (GOPH), closed Thursday's trading session at $1.10, up 14.58%, on 1,013,583 volume with 851 trades. The average volume for the last 60 days is 415,322 and the stock's 52-week low/high is $0.16/$4.85.

chart

Dais Analytic Corp. (DLYT)

StockEgg, StockRich, Stockpalooza, Money Morning, Penny Stock Rumble, FeedBlitz, M2 Communications, HotOTC, SmallCap Pulse, BullRally, SmallCapVoice, CoolPennyStocks, MadPennyStocks, PennyInvest, PennyStockVille, and Greenbackers reported previously on Dais Analytic Corp. (DLYT), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Dais Analytic Corp sells its industry-changing nanomaterial technology into the worldwide water, air, and energy markets. A commercial nanotechnology materials business, the Company provides nanotechnology-based applications for heating & cooling, water treatment, and energy storage. It is commercializing its inventive Aqualyte™ family of nano-structured materials and processes focusing on disruptive air, energy, and water applications. Dais Analytic is based in Odessa, Florida.

The uses of the Aqualyte™ family of nano-structured materials and processes include ConsERV™. This is a commercially available engineered energy recovery ventilator (a heating, ventilation, and air conditioning (HVAC) product). Additionally, the uses include NanoAir™. This is an early beta-stage water-based, no fluorocarbon producing refrigerant cooling cycle.

Uses also include NanoClear™. This is an early beta-stage method for treating contaminated water to provide 1,000 times cleaner potable water. The NanoClear™ process has consistently shown that Dais Analytic’s novel Aqualyte® material can separate most contaminants from water, attaining almost 'parts per billion' clean product water with little or no fouling of the vital membrane component.

NanoClear™ is a cutting-edge water cleaning architecture enabled by the features in the Company’s nanomaterial - Aqualyte™. The NanoClear™ product line is a vital application in purifying contaminated water having high salt content, low pH, or where the need for Total Dissolved Solid (TDS) in the product water is 10 or less.

Uses also include NanoCAP™. Dais indicates that NanoCAP™ holds promise to use the Aqualyte™ family to form a disruptive, non-chemical, energy-storage device (an ultra-capacitor) when completed for use in transportation, renewable energy, as well as 'smart grid' configurations.

In June 2017, Dais Analytic announced that it delivered its initial Environmental Navigator™ System in China. The Company also signed up its first new in-country Distributor who has started selling this new advanced product. The Environmental Navigator considerably improves Indoor Air Quality (IAQ) by providing fresh, filtered air with less airborne particles in the indoor space.

The Environmental Navigator utilizes Dais Analytic's award-winning ConsERV™ Energy Recovery Ventilator technology to precondition this fresh air, delivering up to 70 percent energy savings managing ventilation air and in numerous situations the ability to downsize the HVAC plant size by up to a 1/3rd.

Recently, Dais Analytic announced it signed a 7 year, non-exclusive agreement with the Menred Group, Zhejiang province, China. This agreement is to provide its Aqualyte moisture transfer nanomaterial for use in a newer line of Menred energy recovery ventilators (ERV) to sell into the rising Chinese heating, ventilation and air conditioning (HVAC) market.

Dais Analytic Corp. (DLYT), closed Thursday's trading session at $0.04, up 16.03%, on 72,000 volume with 5 trades. The average volume for the last 60 days is 87,769 and the stock's 52-week low/high is $0.01/$0.0875.

chart

Trevali Mining Corporation (TREVF)

Investopedia, Stockwatch, Streetwise Reports, MarketWatch, OTC Markets, InvestorsHub, Stockhouse, Investing News, Resource World, StreetInsider, Junior Mining Network, Northern Miner, TipRanks, YCharts, Marketwired, Capital Cube, Mining.com, GuruFocus, Stockinvest, and Emerging Growth reported on Trevali Mining Corporation (TREVF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Trevali Mining Corporation is a zinc-focused, base metals company headquartered in Vancouver, British Columbia. Its strategy includes attaining mid-tier Mining Company status through a combination of organic growth and unique deals and strategic alliances. The Company is a pure-play producer with industry-leading leverage to zinc with 80 -85 percent of revenue coming from zinc production.

Trevali Mining is focusing exploration activities in highly prospective, under-explored terrain in nations and regions that offer security of tenure and support mineral deposit development. Production has risen annually for five straight years. Resources at all mines remain open for expansion with exploration drill programs continuing. Glencore is a cornerstone strategic shareholder - 25.6 percent.

Trevali Mining has four mines. These are the wholly-owned Santander mine in Peru, the wholly-owned Caribou mine in the Bathurst Mining Camp of northern New Brunswick, the Company’s 80 percent owned Rosh Pinah mine in Namibia, and its 90 percent owned Perkoa mine in Burkina Faso.

The Rosh Pinah mill re-grind circuit completed in Q4. It is expected to boost recoveries and increase concentrate quality.

Concerning the Bathurst Mining Camp, Trevali Mining acquired five strategic mineral claim blocks from partner Glencore subject to a 2 percent NSR (Net Smelter Return) for any future production for a total of 3,520 ha of area, expanding Trevali's total land holdings to 11,380 ha in the Camp.

Furthermore, the Company owns the Halfmile and Stratmat base metal deposits in New Brunswick. At present, these are undergoing a Preliminary Economic Assessment (PEA) reviewing their potential development.

Puma Exploration, Inc. and Trevali Mining completed their Phase 1 Drilling Program on the Murray Brook Deposit. The Murray Brook Deposit - the core of the Strategic Alliance between the companies - is 10 kilometers west of Trevali’s Caribou Mine and 10 kilometers east of Trevali’s Restigouche Deposit in the Bathurst Mining Camp of New Brunswick. The Program comprised 4,481 meters of drilling within 13 new holes and the deepening of hole MB17-01.

Trevali Mining Corporation (TREVF), closed Thursday's trading session at $0.53, down 1.92%, on 5,700 volume with 4 trades. The average volume for the last 60 days is 116,524 and the stock's 52-week low/high is $0.454/$1.37.

chart

Beleave, Inc. (BLEVF)

NetworkNewsWire, The Street, InvestorsHub, Business Insider, InvestingNews, Cannabis Newswire, ResearchPool, 4-Traders, MidasLetter, Daily Marijuana Observer, Weed Newswire, Penny Stock Tweets, OTC Markets, New Cannabis Ventures, Equities, MarketWatch, Morningstar, Wallet Investor, InvestorsHangout, Stockhouse, Barchart, PrimedEquities, Marketwired, and TradingView reported on Beleave, Inc. (BLEVF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Beleave, Inc. is a diversified biotechnology company with a purpose-built ACMPR licensed cannabis facility near Hamilton, Ontario. Moreover, it has patient services clinics operating throughout Ontario under the Medi-Green brand. The Company's wholly-owned subsidiary is Beleave Kannabis Corp. Beleave lists on the OTC Markets Group’s OTCQX.

The Company has decades of growing experience coupled with industry leading equipment. Beleave’s aim is to provide a consistent, reliable and standardized product to suit the needs of every person.

Beleave concentrates on green initiatives. It grows its plants using no pesticides. In addition, the Company’s facilities host a large-scale, commercial, solar installation, which substantially offsets its carbon footprint. Beleave’s water supply is on a closed loop system to recycle every drop.

Beleave’s products include Shishkaberry, CBD god bud, and Cold Creek Kush. Shiskaberryʼs buds have a fruit and berry aroma with shades of purple. CBD god bud was created by mixing an almost pure Sativa strain named Hawaiin with a very strong purple Indica strain. Cold Creek Kush is an Indica-dominant hybrid. It crosses the strong MK Ultra and Chemdawg 91.

In May, Beleave announced that it added another location to its network of Medical Cannabis Clinics. The new location is located at 211 Dundas Street in London, Ontario. The Company recently closed on the acquisition of the Medi-Green Cannabis Clinic Network.  London, Ontario is Beleave’s fourth clinic joining three Ontario locations already open in Hamilton, Kingston, and Perth.

In July, Beleave announce the acquisition of 100 percent of the outstanding shares of Seven Oaks, Inc. in an all share deal valued at $3,000,000. This acquisition follows important news of Seven Oaks branded cannabis products being chosen by Manitoba Liquor and Lotteries Corporation and the BC Liquor Distribution Branch for sale to consumers in deals anticipated to generate initial revenues of more than $2,900,000. Beleave is preparing to launch Seven Oaks-branded cannabis flower, pre-rolls, as well as oils after October 17, 2018.

This week, Beleave announced it was selected by the Ontario Cannabis Store (OCS) for sale of its Seven Oaks brand. Beleave will package and sell three strains of its cannabis products under the Seven Oaks brand at launch. The Company will continue to expand options for consumers as new varieties become available.

Beleave, Inc. (BLEVF), closed Thursday's trading session at $1.22, down 5.38%, on 261,772 volume with 407 trades. The average volume for the last 60 days is 117,880 and the stock's 52-week low/high is $0.847/$2.80.

chart

Green Cures & Botanical Distribution, Inc. (GRCU)

Penny Stock Tweets, InvestorsHub, OTC Markets, Business Insider, ClayTrader, Stockopedia, Barchart, GuruFocus, StockGoodies, Capital Cube, Zacks, Front Page Stocks, Simply Wall St, MarketWatch, Stockhouse, Marketwired, Investors Hangout, and Daily Marijuana Observer reported on Green Cures & Botanical Distribution, Inc. (GRCU), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Green Cures & Botanical Distribution, Inc. (GRCU) is a hemp-infused nutrition, botanical, sports, and body care products business. The Company operates a diverse portfolio of products and services within the botanical and cannabis industry, as permitted by law. GRCU is continually creating and introducing products that promote a healthy life style. Listed on the OTC Markets, the Company is based in California.

GRCU announced this past April the expansion of its corporate offices into a new space located in Woodland Hills, California. Also, the Company has received approval from California for GRCU's newest manufacturing plant.  The plant had been approved for recreational manufactory and sales in the State of California.

GRCU is currently Web-based. The Company’s focus is on online retailing. Its products are branded under the Original Hollywood Hemp™ brand. Furthermore, it develops beverages branded under the Iconic Beverages ™ name.

Original Hollywood Hemp™ is hemp activated health, beauty, skin care, hair care, spices, fashion, food products and beverages with the active ingredients of hemp. Iconic Beverages™ consists of hemp infused and no hemp infused beverages. Iconic Beverages™ will feature iconic celebrities with exclusive licenses owned by GRCU and its shareholders.

GRCU announced in February 2018 that it signed a four-year agreement with Humboldt Cannabis AF in California to produce licensed cannabis and CBD products. Humboldt Cannabis AF is a cannabis and CBD company in Humboldt, California.

GRCU will look to products to be sold at retail/dispensary. Nevertheless, the Company will rely on Humboldt Cannabis AF for CBD product development. Humboldt has a track record producing top of the line, exclusively pristine product.

In addition, vibrant packaging design for the new GRCU product lines has been finalized. GRCU products are being packaged in their new, striking, provocative, Must Have Packages.

Moreover, GRCU provides online community portals. These sites supply the public with information and resources concerning the benefits of cannabis-derived products.

Green Cures & Botanical Distribution, Inc. (GRCU), closed Thursday's trading session at $0.0079, up 6.76%, on 3,368,345 volume with 79 trades. The average volume for the last 60 days is 622,007 and the stock's 52-week low/high is $0.0051/$0.0565.

chart

MPX Bioceutical Corporation (MPXEF)

Jet Life Penny Stocks, TalkMarkets, Barchart, Penny Stock Hub, Stockhouse, MarketWatch, InvestorsHub, Stockwatch, Investorx, 4-Traders, TradingView, OTC Markets, OTC Dynamics, Investing News Alerts, and High Rising Stocks reported on MPX Bioceutical Corporation (MPXEF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

MPX Bioceutical Corporation, through its wholly-owned subsidiaries in the United States, provides management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services to two medicinal cannabis businesses in the State of Arizona. These businesses operate under the Health for Life (dispensaries) and the award-winning Melting Point Extracts (high-margin concentrates wholesale) brands. MPX Bioceutical also has operations in Massachusetts.

MPX Bioceutical’s shares trade on the OTC Markets Group’s OTCQB. The Company previously went by the name The Canadian Bioceutical Corporation. It changed its name to MPX Bioceutical Corporation in November of last year. The Company is headquartered in Toronto, Ontario.

MPX Bioceutical is a multi-state diversified cannabis business. The Company has operations centered in the United States in the adult use and medical cannabis markets. It has completed its agreement to acquire GreenMart operations in Nevada. MPX has also applied for a license in Canada.

Regarding Pharma-grade products, MPX signed a definitive agreement to establish a joint venture (JV) with Panaxia. This JV is to develop proprietary, smokeless pharma-grade products using cannabis.

MPX Bioceutical announced this past April that it signed a Letter of Intent (LOI) to acquire 100 percent of the issued and outstanding shares of Canveda, Inc.  Canveda is a Licensed Producer under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). Canveda is a private company operating in Peterborough, Ontario. It operates from a completely built-out facility that is capable of producing roughly 1,000-1,200 kilograms of high quality cannabis flower annually.

At the beginning of August, MPX Bioceutical announced that it, via its indirect wholly-owned subsidiary, S8 Management, LLC, received final licensing approval by the Maryland Medical Cannabis Commission for the opening of two managed dispensaries, LMS Wellness, Benefit LLC (LMS), operating as Health for Life White Marsh, and GreenMart of Maryland, LLC (GreenMart Maryland), operating as Health for Life Baltimore.

Health for Life White Marsh will operate a dispensary in the White Marsh suburb of Baltimore, Maryland. Health for Life Baltimore will operate a dispensary in an urban, high-traffic area of Baltimore, near North Point Road in the community of Colgate.

MPX Bioceutical has expanded its Arizona footprint via the acquisition of The Holistic Center (THC) dispensary. This brings MPX’s total number of dispensaries in the state to four. It doubles the Company’s cultivation capacity. It also adds the Black Label and Timeless concentrate brands to its product offerings.

MPX has also entered into a definitive agreement with Panaxia Pharmaceutical Industries Ltd. Panaxia is an Israeli company. It engages in the business of development and production of pharma grade cannabidiol medicinal products, medicinal preparations, and medicinal accessories via MPX’s wholly-owned subsidiary Salus BioPharma Corporation.

MPX Bioceutical Corporation (MPXEF), closed Thursday's trading session at $0.62, even for the day, on 1,122,000 volume with 335 trades. The average volume for the last 60 days is 746,389 and the stock's 52-week low/high is $0.2257/$0.935.

chart

OriginClear, Inc. (OCLN)

MarketWatch reported on OriginClear, Inc. (OCLN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OriginClear, Inc. is a top provider of water treatment solutions. The Company is also the developer of a unique water cleanup technology. Through its wholly-owned subsidiaries, OriginClear provides systems and services to treat water in a wide array of industries. These include municipal, pharmaceutical, semiconductors, industrial, as well as oil & gas. The Company has its wholly-owned subsidiary, Progressive Water Treatment (PWT) of Dallas, Texas.
OriginClear is based in Los Angeles, California.

OriginClear invented Electro Water Separation™. This is a cutting-edge high-speed water cleanup technology utilizing multi-stage electrolysis that OriginClear licenses internationally to water treatment equipment manufacturers. Electro Water Separation™ (EWS) is a highly scalable, continuous process. It uses electricity in small, programmed doses to gather up oils and suspended solids. In addition, by way of Advanced Oxidation or AOx, it removes fine, micron-sized suspended solids, and dissolved contaminants, including ammonia.

OriginClear’s mission is to develop Electro Water Separation™ with Advanced Oxidation™ (EWS:AOx™) and accomplish its full recognition as a global industry standard in treating increasingly complex wastewater treatment challenges.

OriginClear has entered into a Master Research Agreement with Florida Atlantic University (FAU) in Boca Raton, Florida. The Agreement establishes a cooperative framework for further scientific research and validation projects concerning the Company’s technology, Electro Water Separation with Advanced Oxidation (EWS:AOx), when applied to landfill leachate treatment.

In August 2017, OriginClear announced that recent testing in the La Kretz Advanced Prototyping Center demonstrated the ability to virtually eliminate the herbicide glyphosate from drinking water by up to 99.3 percent. Glyphosate is the world's leading herbicide.

OriginClear Engineer Ayush Tripathi mixed glyphosate in tap water to a concentration of roughly 300 parts per million (ppm), with 300 ppm salt, and processed it utilizing direct and indirect methods, using lab-scale models of OriginClear's AOx patent-pending Advanced Oxidation Process. The results, as analyzed by a certified laboratory, varied between 95.8 percent and 99.3 percent of glyphosate removal, depending on the method employed.

Furthermore,  in September, OriginClear announced that new testing at the La Kretz Advanced Prototyping Center demonstrated real-time removal of glyphosate, the active ingredient in Roundup®, at concentrations of parts per billion. This represents a quantum increase over earlier testing in the range of parts per million.

OriginClear, Inc. (OCLN), closed Thursday's trading session at $0.0058, up 38.10%, on 25,646,413 volume with 198 trades. The average volume for the last 60 days is 2,226,105 and the stock's 52-week low/high is $0.0024/$0.125.

chart

Pharma-Bio Serv, Inc. (PBSV)

Zacks reported previously on Pharma-Bio Serv, Inc. (PBSV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Pharma-Bio Serv, Inc. is a compliance, project management, and technology transfer support consulting firm. The Company’s primary business is Food and Drug Administration (FDA) and other international regulatory compliance agency related services, with integrated portfolio services including microbiological and chemical testing services. This includes microbiological and chemical testing services for clients in the Pharmaceutical, Biotechnology, and Chemical, Medical Device, Cosmetic, Food and Allied Products industries, at its laboratory testing facility in Puerto Rico. Pharma-Bio Serv is based in Dorado, Puerto Rico. The Company also has operations in the U.S., Ireland, and Spain.

Pharma-Bio Serv supports its clients by way of the product lifecycle. This includes research and development (R&D) Studies; NDA Documentation and Filings; PAI Readiness; Audit & Inspection Preparation, Management and Response, and Post Approval. Furthermore, this includes Quality Systems; Technology Transfer; Validation, and Manufacturing Controls & Process Support.

The Company’s worldwide team includes top engineering and life science professionals, quality assurance managers, as well as directors. Also, the Company’s services include "Pharma Serv Academy." This division provides technical and regulatory standards seminars/training conducted by industry experts. 

Pharma-Bio Serv’s divisions include Scienza Labs, the abovementioned PharmaServ Academy, and Metrologix. Scienza Labs provides microbiological and analytical testing, field support, method development, and validation. Metrologix provides laboratory and on-site calibration services, calibration program management, risk management, compliance remediation, and instrument rental.

This past September, Pharma-Bio Serv announced Net Revenues for the three and nine months ended July 31, 2017 were $4.0 and $11.9 million, respectively. This represents a decrease of roughly $0.9 and $2.9 million, or 18.2 percent and 19.8 percent, respectively, versus the same periods the year prior.

The decrease for the three months ended July 31, 2017, versus the same period last year, is primarily because of a decline in projects in the Puerto Rico consulting market of $0.9 million. The Company’s other divisions sustained minor revenue gains/losses or remained constant, versus the same period the year prior.

Mr. Victor Sanchez, Pharma-Bio Serv’s Chief Executive Officer, said, "Our strategic re-alignment and investment is ongoing and our goals are to achieve long-term profitability on our non-performing operations. To that end Europe is a focus for our attention, we have also refocused our US consulting services strategy with a more streamlined business development approach, which has resulted in operational expense savings during the second and third quarters of the current fiscal year…”

Pharma-Bio Serv, Inc. (PBSV), closed Thursday's trading session at $0.60, up 9.09%, on 1,000 volume with 2 trades. The average volume for the last 60 days is 13,832 and the stock's 52-week low/high is $0.325/$0.70.

chart

Viscount Mining Corp. (VLMGF)

MarketWatch reported on Viscount Mining Corp. (VLMGF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Viscount Mining Corp. is a project generator building a portfolio of first-class exploration properties in friendly mining jurisdictions in the United States. The Company’s projects include Cherry Creek (Nevada – 100 percent owned) and Silver Cliff (Colorado). Cherry Creek is its flagship property. Viscount Mining is based in North Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQB.

Viscount Mining’s flagship property is focused on exploratory mining operations in the immediate vicinity of an area generally known as the Cherry Creek Project, situated approximately 30 miles north of the town of Ely, in White Pine County, Nevada. Currently, the Cherry Creek claims consist of more than 400 unpatented and patented claims and also mill rights.

Furthermore, the Company’s Silver Cliff property is within the historic Hardscrabble Silver District. It consists of 96 lode claims where high grade silver, gold, and base metal production came from numerous mines during the period 1878 to 1894. The Silver Cliff property is 44 miles WSW of Pueblo, Colorado.

In May 2017, Viscount Mining reported drill results for all holes twinned in 2016 on the Silver Cliff property in the Hardscrabble Silver District of Custer County, Colorado. This program, which began in mid-November, met its main goal of confirming the general validity of historical drill intersections of silver mineralization on one of the Silver Cliff deposits called the Kate Silver Resource (KSR).

Recently, Viscount Miningannounced that it entered into a long term extension on the previous access and mineral rights agreement for the area at Silver Cliff including the Kate Deposit (KSR) positioned adjacent to the Town of Silver Cliff in Colorado. The final lease/option agreements entered into with the underlying holders of the mineral rights are consistent with the earlier announced terms and conditions. They now provide for greater security and certainty of Viscount Mining's rights and interests.

In addition, Viscount Mining recently announced the appointment of Dr. Gilles Arseneau to complete an NI 43-101 Report of its historical and current data from drilling and sampling at its Silver Cliff Project. Dr. Arseneau holds a Ph.D Geology, from Colorado School of Mines, an M.Sc from the University of Western Ontario, 1984, and a B.Sc Univ. of New Brunswick.

Viscount Mining Corp. (VLMGF), closed Thursday's trading session at $0.195762, up 4.41%, on 30,800 volume with 3 trades. The average volume for the last 60 days is 11,077 and the stock's 52-week low/high is $0.1729/$0.3211.

chart

The QualityStocks Company Corner

Cannabis Strategic Ventures, Inc. (OTC: NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Shares of Cannabis Strategic Ventures, Inc. (OTC: NUGS) surged by more than 30 percent in Thursday morning trading following news earlier in the week of the company’s acquisition of The Asher House Pet CBD brand from The Asher House LLC. To view a detailed quote, visit: http://nnw.fm/yZ9oh.

Cannabis Strategic Ventures, Inc. (OTC: NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $5.49, up 37.94%, on 910,894 volume with 2,312 trades. The average volume for the last 60 days is 42,635 and the stock's 52-week low/high is $0.031/$7.13.

Recent News

chart

Marijuana Company of America Inc. (OTC: MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Marijuana Company of America Inc. (OTC: MCOA), a client of CNW that focuses on product research and development of legal hemp-based consumer products containing CBD under the brand name “hempSMART™”, an affiliate marketing program to promote and sell its products, as well as leasing of real property and expansion of business into ancillary areas of the legalized cannabis and hemp industry. To view the full publication, titled “As Senate Brings Legal Change, Hemp Offers Hope for American Farmers,” visit: http://cnw.fm/7Ltny. Also today, NetworkNewsWire released a report on the company detailing MCOA’s shares rising more than 7% Thursday afternoon following an update issued earlier in the week regarding the company’s CBD hemp farming joint venture with Global Hemp Group (CSE: GHG) (OTC: GBHPF) in New Brunswick, Canada.  

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0313, up 10.99%, on 20,106,885 volume with 696 trades. The average volume for the last 60 days is 7,715,988 and the stock's 52-week low/high is $0.022/$0.0728.

Recent News

chart

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF)

The QualityStocks Daily Newsletter would like to spotlight Lithium Chile Inc. (LTMCF).

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF) is pleased to announce that lithium-bearing brines have been intersected by the first of four drill holes at its wholly-owned Ollague project located in the Antofagasta Region of Chile.   Hole DDH-OLL-01-18 encountered an aquifer hosting lithium-bearing brines at a depth of 110 meters which continued to a depth of 290 meters. This continuous 180-meter zone of brine returned grades of up to 480mg/L lithium. The average grade over the last 60 meters was 470 mg/L lithium.

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF), headquartered in Canada, is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex. The company’s wholly owned premier properties include 66 square kilometers on the Salar de Atacama, Chile’s largest mineral salt flat which hosts the world’s highest concentration of lithium brine production and is currently the source of about 35 percent of the world’s lithium production. Lithium Chile also owns a significant copper/gold/silver property portfolio consisting of 28,184 hectares over six different properties.

Lithium Chile’s portfolio in the heart of Chile’s lithium-rich salars includes Salar de Coipasa, Salar de Helados, Salar de Atacama, Salar de Turi Salar de Ollague and Salar de Talar. Surface and near surface salt and brine sampling programs on all properties has been completed. To date, samples of high-grade, near-surface lithium brines at each of these projects are showing excellent chemistry of lithium to potassium and lithium to magnesium ratios. Good chemistry is important as it reduces your overall cost of production. Recent geophysical surveys including T.E.M have been completed on 5 of 6 priority targets and data collected to date has been extremely encouraging.

Lithium Chile has identified multiple high-priority brine target areas at its Atacama and Ollague lithium project areas. These areas display the same geophysical characteristics as the lithium-rich aquifers at Salar de Atacama, home to the world’s largest and highest-grade lithium brine producers. Spanning an area of 1,200 square miles, Salar de Atacama is the world’s third largest salt flat behind Salinas Grandes in Argentina and El Salar de Uyuni in neighboring Bolivia. Exploration drilling and resource definition drilling for these target areas are planned for 2018.

“We are delighted with the discovery of such impressive drill target areas at Atacama and Ollague. The results also follow the recent discovery of a 60km2 target area at another of our top Chilean projects – Helados – where we hope to drill in the second quarter of 2018,” stated President and CEO Steve Cochrane. “We have an aggressive multi-project drill program planned for this year, which includes all three of these exciting projects and we look forward to sharing drill results as they come through.”

Global demand for lithium-ion batteries is expected to surpass US$53 billion by 2024 as governments around the world aggressively seek to ban gas-powered vehicles and major automakers invest billions in new technology and electric vehicles powered by lithium-ion batteries. Chile’s mining-friendly jurisdiction offers Lithium Chile a clear, streamlined permitting process that significantly lowers the cost of lithium production to around $1,800/ton as compared to Australia’s $5,000/ton.

Lithium Chile is led by an experienced team with strong Chilean connections. Cochrane’s 36 years of investment industry experience have primarily been focused on the mining sector. During this time, he raised more than US$500 million for a variety of small cap public companies in various businesses and industry sectors including mining.

Terry Walker, P.Geol., vice president of exploration and chief geologist, is a highly experienced geologist. He has spent over 25 years in Chile’s mining industry and is well connected throughout the sector. Walker is co-founder of GeoServicios Piedra Dorada, an exploration and development services company focused on Latin America. He is a Qualified Person for the North American and Australian stock exchanges.

Lithium Chile is well funded and driven by a top-tier team with more than 100 years of combined experience in financing, mining exploration and development in the natural resources sector.

Lithium Chile Inc. (LTMCF), closed the day's trading session at $0.63, up 4.22%, on 18,416 volume with 19 trades. The average volume for the last 60 days is 50,806 and the stock's 52-week low/high is $0.535/$0.97.

Recent News

chart

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF).

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) yesterday issued a shareholder update on its ongoing corporate initiatives. To view the full press release, visit: http://cnw.fm/6AbJW.

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.

The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.

PreveCeutical Medical Inc. (PRVCF), closed the day's trading session at $0.03008, up 3.72%, on 76,682 volume with 23 trades. The average volume for the last 60 days is 625,001 and the stock's 52-week low/high is $0.002/$0.20.

Recent News

chart

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

Choom™ (CSE: CHOO) (OTCQB: CHOOF) (the "Company" or "Choom") an emerging, fully-integrated cannabis company, is pleased to announce that it has advanced its retail portfolio and the build-out of its cannabis retail store network in Alberta and British Columbia.

Choom Holdings Inc. (OTCQB: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.892, up 2.53%, on 346,734 volume with 308 trades. The average volume for the last 60 days is 589,144 and the stock's 52-week low/high is $0.153/$1.13.

Recent News

chart

DPW Holdings, Inc. (NYSE American: DPW)

The QualityStocks Daily Newsletter would like to spotlight DPW Holdings, Inc. (DPW).

DPW Holdings, Inc. (NYSE American: DPW), a diversified holding company, today announced that the historic Valatie Falls, New York hydroelectric dam will become operational during the fourth quarter of 2018 to serve as a fully-dedicated source of low-cost, renewable power for a new co-located cryptocurrency mining farm to be built and operated by DPW’s wholly-owned Super Crypto Mining subsidiary.

DPW Holdings, Inc. (NYSE American: DPW), is a diverse holding company pursuing a growth strategy of  acquiring undervalued assets with disruptive technologies with a global impact.

The company invests in diverse industries within the commercial, defense/aerospace, industrial, communication, medical, crypto-mining, hospitality, textile, and corporate investment/lending sectors. DPW has evolved and grown from being a leader in advanced power products. Through its subsidiaries, the company continues to be a leader and supplier of innovative technologies, advanced design and development services, and state-of-the-art power products and solutions.

Through its wholly owned Coolisys Technologies, Inc. subsidiary, DPW is committed to offering world-class technology-based solutions for critical applications and lifesaving services that are primarily driven by innovation. Coolisys targets to the defense, aerospace, naval, homeland security, medical, telecom, datacom and industrial markets. Its growth strategy centers on core markets that are characterized by “high barriers to entry” and require specialized products and services not likely to be commoditized. Through a portfolio of companies, Coolisys is engaged in developing and manufacturing advanced switching power products and power solutions that utilize a customized digital power management and resonant topology to attain:

  • The highest efficiency and highest density power converters and inverters
  • Specialized complex airborne high-frequency, radio frequency (RF), and microwave detector-log video amplifiers (DLVA)
  • Very high-frequency filters
  • Naval power conversion and distribution equipment

Coolisys offers its technology and services through three primary groups: the Power Solutions Group (PSG), the Defense and Aerospace Solutions Group (DSG), and the Advanced Service Industries (ASI) Group. Coolisys manages five divisions:

  • Digital Power Corporation, a leader in providing power electronics technology that is based in northern California.
  • Digital Power Limited dba Gresham Power Ltd, a designer and manufacturer of power distribution systems primarily for Naval use that is based in Salisbury, UK.
  • Microphase Corporation, a designer and manufacturer of microwave electronics technology that is based in Shelton, Connecticut.
  • Power-Plus Technical Distributors, a value-added distributor that is based in Sonora, California.
  • Enertec Systems, a developer and manufacturer of specialized advanced electronic systems for the defense and aerospace sectors that is based in Karmiel, Israel.

DPW’s portfolio of wholly owned subsidiaries also includes Digital Power Lending, LLC (DPL), a California private lending company operating under Financial Lender’s License ##60DBO-77905. DPL is dedicated to strategically providing capital to small and middle-size businesses for an equity interest in addition to loan fees and interest. DPL provides secured and unsecured debt financing for public and private companies. These loans will typically have a six to 12-month maturity and range from $250,000-$5 million. DPL is active in bridge loans, receivable financing, inter company loans and micro loans. DPL will work with a network of company owned ATMs (terminals) in California, which will help utilize its CA Finance Lending License and enable the company to offer micro loans of up to $500 or less.

Management has over 50 years of Wall Street experience of investing in, and building companies. DPL’s desire is to bring world-class companies lending opportunities while allowing main street investors to participate. Deal flow and organization comes from an extensive network of investment bankers, business brokers, family offices, and institutional clients enabling DPL to engage and fund the most compelling companies from Silicon Valley to Wall Street.

To date, DPL has funded over $19 million in loans. Since inception, DPL has internally funded over $15 million to DPW’s portfolio companies and wholly owned subsidiaries. As for companies outside DPW, DPL has lent over $4 million in commercial and real estate loans. DPL has funded INVO Bioscience, Medovex, Parallax, Alzamend Neuro, as well as hospitality clients, such as Guilia DTLA and Prep Kitchens.

Another subsidiary wholly owned by DPW is Super Crypto Mining, Inc., a cloud computing service that provides shared and managed computing resources optimized for various block chain mining solutions. Based in Newport Beach, California, Super Crypto Mining leverages its engineering expertise and existing locations to create cryptocurrency mining facilities throughout the world. The company owns and maintains the computing resources and sells access to their use. The established mining is on the Top 3 crypto-currencies with the goal of having 10,000 miners deployed in 2018. Super Crypto Mining endeavors to leverage its engineering expertise and existing global facilities (high-security defense business locations) to secure mining farms. Super Crypto Mining is a rapidly growing organization that recently strategically secured 25 mega watts to power the company’s mining farm. For crypto currency mining, locations with inexpensive power and secure capacity are minimal and hence costly. Having such a location allows the company to grow its mining business to more than 20,000 mining machines. Super Crypto Mining continues to purchase mining machines and explore opportunities to expand its services into other related areas including mining farm real estate investments, mining machine development, and mainstream blockchain projects.

DPW additionally has beneficiary ownership in MTIX International, Inc., the parent company of MTIX, Ltd. and I.AM, Inc.

MTIX was acquired by Avalanche International aka MTIX International, Inc., in August 2017 and offers “green technology” that uses a proprietary laser process to enhance the surface of textiles. This process reduces water usage by approximately 75 percent, reduces greenhouse gases by approximately 90 percent, and reduces chemical use by approximately 95 percent.

I.AM, acquired in May 2018, owns and operates hospitality offerings that include four Prep Kitchen brand restaurants and Giulia DTLA.

Utilizing a shareholder-centric approach to compensation, DPW has formulated the following 10-year objectives:

  • Achieve compounded annual revenue growth of 25-35%
  • Achieve compounded annual net Income growth of 5%
  • Achieve positive unrestricted free cash flow by the end of 2019

DPW is led by a seasoned team of successful business professionals and entrepreneurs. The company is headquartered in Newport Beach, California.

DPW Holdings, Inc. (DPW), closed the day's trading session at $0.404, up 0.27%, on 463,425 volume with 753 trades. The average volume for the last 60 days is 1,911,088 and the stock's 52-week low/high is $0.389/$5.95.

Recent News

chart

GreenBox POS, LLC (OTC: GRBX)

The QualityStocks Daily Newsletter would like to spotlight GreenBox POS, LLC (GRBX).

GreenBox POS, LLC  (USOTC: GRBX) ("GreenBox", "the Company") announced today it received notification from OTCMarkets yesterday, August 22, 2018, that it will be required to re-file its disclosure information and most recent Form 10-Q in order to effectively state its corporate structure and meet the OTCQB transparency requirements.

GreenBox POS, LLC (OTC: GRBX) is a hardware and software technology company that builds customized payment solutions in different industries. The company is headquartered in San Diego, California, with offices in Seattle, Wash.; Las Vegas, Nevada; and Vancouver, British Columbia, Canada. GreenBox, which has been awarded five provisional patents for its blockchain-based technology, delivers a fully integrated, intuitive, easy-to-use, point of sale (POS) system for a variety of businesses across a multitude of different market sectors.

GreenBox develops all software in-house and with international subsidiaries, which allows the company to provide individualized electronics modifications in partnership with different vendors. Custom POS machines are available as an upgrade from existing solutions currently in use. First-time merchants can also take advantage of custom-built kiosk machines powered by blockchain technology, complete with e-wallet integration downloadable via Android or iOS apps, or via installed cash-loading kiosks.

GreenBox develops POS (point of sale) software and hardware solutions; DEL (delivery app, APIs to POS and PAY); PAY (payment app, providing financial APIs to all other components); and KIOSK (deposit, cash and E-wallet management). The following flagship products, services and custom hardware are currently available:

  • QuickCard – the QuickCard kiosk handles all cash issues, both for cashless operations and for legacy cash; performs direct and immediate deposits from cash to blockchain and confirms bank account availability within minutes. Accepts cash, debit/credit cards, or ACH directly to most banks while settling funds instantly. All records are stored securely on blockchain. No faster deposit solution is available in the regular and non-traditional banking systems (unless depositing cash directly into a cash machine connected to a bank branch).
  • POS Solutions – GreenBox software, developed in-house and with international subsidiaries, features operational compliance, financial audit prep, expense tracking, tax payments, register-specific features, and data fidelity controls (backup/restore, cloud security, privacy, etc.). GreenBox POS software is fully integrated with Del and Pay Systems and features front register mode and back-end admin mode, in addition to in-admin mode to manage employees, vendors, expenses, taxes and compliance. All records are stored on blockchain with data reliably secured and protected.
  • LOOPZ – This delivery software solution offers service dispatcher back-end technology with manual and automatic modes. The software is uniquely designed to be effectively utilized for mobile delivery service operations with full autonomous dispatch capabilities. LOOPZ provides the following features: two mobile apps (driver and consumer) running on Android and IOS; direct reporting to point of sale inventory and use of pay for instant settlements; separate escrow setup for tips and merchant sale; all data and information is securely hosted on a blockchain platform.

The management team at GreenBox includes CEO Fredi Nisan, who comes from the POS and merchant services business sector. He recently completed a successful exit in the POS and ERP business, which he founded and managed through the exit. Joining Nisan is Ben Errez, executive vice president, who comes from the investment, consulting and big software and hardware industries. His previous executive roles include positions at Microsoft (including engineering management of Microsoft Office for complex scripts); IBM (with which he had an exit); and Intel. Errez has also consulted the world’s biggest private economy, World Trade Center, on payment systems, security, reliability and privacy of software and hardware development.

GreenBox POS, LLC (GRBX), closed the day's trading session at $0.90, even for the day, on 6,793 volume with 8 trades. The average volume for the last 60 days is 54,828 and the stock's 52-week low/high is $0.017/$1.95.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) highlighted today in a report on the CBD industry. According to a new report from New Frontier Data, the CBD industry is set to grow to $2 billion by 2022—after witnessing that in the US alone, the CBD industry grew by nearly 40% in 2017.

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $3.90, even for the day, on 139,776 volume with 441 trades. The average volume for the last 60 days is 238,304 and the stock's 52-week low/high is $2.784/$7.565.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), a client of NNW engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry. To view the full publication, titled “Conversations Between Cars and Their Environment Complement Sensor Systems for a Safer Self-Driving Future,” visit: http://nnw.fm/yYZz0.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $2.999, up 4.48%, on 25,612 volume with 65 trades. The average volume for the last 60 days is 55,969 and the stock's 52-week low/high is $2.44/$8.20.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Formula One racing is not the only place to find speed. The drug delivery platform DehydraTECH™, developed by Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), has proven that it’s just as fast. In recent in vivo tests, the technology delivered 203 nanograms per milliliter (ng/mL) of nicotine in 15 minutes, 70 percent more than the control. Such rapidity may rival smoking; particularly as new research (http://nnw.fm/PMz57) suggests that “nicotine takes much longer than previously thought to reach peak levels in the brains of cigarette smokers.”

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.98, off by 3.41%, on 227,923 volume with 296 trades. The average volume for the last 60 days is 245,656 and the stock's 52-week low/high is $0.322/$2.54.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International, Inc. (NASDAQ:YGYI) was highlighted today in an article examining the hotly-contested commercial coffee market. Also today, NetworkNewsWire released a report on the company detailing how leading omni-direct lifestyle company YGYI is “One to Watch.”

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $4.1044, off by 2.28%, on 43,892 volume with 143 trades. The average volume for the last 60 days is 15,183 and the stock's 52-week low/high is $3.1674/$6.75.

Recent News

chart

NUGL Inc. (OTC: NUGL)

The QualityStocks Daily Newsletter would like to spotlight NUGL Inc. (NUGL).

With the cannabis industry entering the mainstream in a big way, there is a growing need among consumers to be able to find reliable products and services or even specific brands. Technology company NUGL Inc. (OTC: NUGL) seeks to address this major pain point and help customers overcome the challenge of finding reputable and reliable supplies of specific products and services.

NUGL Inc. (OTC: NUGL) is focused on leading the evolution in business relations, development and organic data in the cannabis industry with a distinct platform. In this effort, it has developed a leading-edge, first of its kind search app and online directory for the marijuana industry that provides a one-stop source and listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands.

Headquartered in Chino Hills, California, which is home to a projected $5 billion legal marijuana marketplace, NUGL is on track to become a major asset for the global cannabis industry and related services sectors. The company recently established a strategic partnership with Thinklogic and appointed CEO Chris Adams to NUGL’s growing board of directors. Thinklogic is a top-level software development company specializing in projects for start-ups to Fortune 500 companies.

“This strategic partnership puts NUGL in a distinguished class, adding a first-rate technical software expert like Chris gives NUGL a unique technological advantage,” said Brandon Vargas CEO of NUGL. “With the addition of Chris’s knowledge and expertise combined with Thinklogics’ experienced and skilled staff, NUGL will have the ability to evolve and build a strong infrastructure unmatched in the 420 industry.”

NUGL is nearing completion of its initial launch timeline, with plans to launch the app on both Android and iOS platforms within the next few weeks. NUGL’s live testing of its software includes enhanced reviews that detail up to 10 category ratings. Each of the category rankings allow users to leave comments and choose among a 5-star rating among all categories or as few as they wish. The software’s rating platform allows for customization and transparency for users while providing invaluable feedback to shops and professional services.

“This is a major feature that is critical to our community,” said Jeff Odle, NUGL’s CTO. “Enhanced ratings will be a definitive difference validating our organic listings and raising the standard for the industry. We want the users to know what they are getting before they step into a store or sign up for a service.”

Leadership Team

NUGL is growing its team of developers and launching new features on an ongoing basis. The company is ahead of an impressive timeline, which includes building blocks for scalability and massive growth.

“Everything we do is focused on user experience. Our philosophy is simple – make it fun and easy to use, with the purest and most unbiased results,” said Ryan Bartlette, NUGL CMO. “As the industry evolves and becomes more sophisticated, NUGL will adapt and build the best marketing technology for the cannabis-related companies. We have gotten in on the ground level and know the pulse of the industry.”

NUGL CEO Brandon Vargas is a founding member of G6 Management, a full-service consulting firm advising cannabis professionals in all aspects of business. With over 10 years’ experience in the cannabis space, he has worked on dispensary, cultivation and infusion entity formation, licensing, real estate acquisitions, construction and build out, marketing, policy and procedures, compliance, staffing, and capital raises. Vargas has an extensive background working with various medical marijuana companies on investment and in developing greenhouse and commercial cultivation, distillate for vapes cartridges, CBD oils and infusions.

CMO Ryan Bartlette is co-founder and CMO of 23Forty LLC and Boxy. He has expertly positioned and branded many companies while bringing them to market and is a sought out graphic artist, front-end developer, photographer, and visual artist with experience in the entertainment and technology industry.

Jeff Odle, NUGL CTO, is a successful senior software architect has a long and distinguished career developing some of the most innovative, cutting-edge platforms available. His unique and distinctive approach to creating the blueprint for advanced programming is industry leading and unprecedented. He is a top-level architect responsible for developing some of the most forward-­looking software for various industries.

NUGL’s board of directors includes John R. Armstrong, a founding partner of Horwitz + Armstrong, a full service general business firm handling all aspects of litigation and business strategy and advice. Armstrong and his partner, Lawrence Hortwitz, have more than 10 years of experience in the cannabis space, representing cannabis professionals in all aspects of business including business formation, licensing, compliance with local and state regulations, real estate acquisitions, corporate mergers and acquisitions, financing, inclusive of capital raises and alternative financing, contracts, and all forms of dispute resolution.

Board member Hendrik Klein, founder of Da Vinci Asset Management, a privately-owned investment firm, serves as CEO and executive board member of Fritz Nols AG, a capital marketing consulting firm specializing in trading and asset management. Klein has received several industry awards including the Austrian Hedge Fund Award, the German Hedge Fund Award, and most recently was named the Global Best Performing Systematic Quantitative CTA. Klein and the Da Vinci team employ the latest quantitative data research and analysis in their innovative investment strategy.

NUGL Inc. (NUGL), closed the day's trading session at $1.40, off by 0.71%, on 119,145 volume with 142 trades. The average volume for the last 60 days is 119,383 and the stock's 52-week low/high is $0.405/$1.80.

Recent News

chart

Pressure BioSciences Inc. (OTCQB: PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences (OTCQB: PBIO) is collaborating with The Ohio State University and its College of Food, Agricultural and Environmental Sciences (“CFAES”) to create an innovative new method for room temperature storage of beverages and liquid foods without using additives or compromising quality. To view the full article, visit: http://nnw.fm/tsBh2.

Pressure BioSciences Inc. (OTCQB: PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $3.21, off by 10.83%, on 6,342 volume with 23 trades. The average volume for the last 60 days is 1,535 and the stock's 52-week low/high is $0.70/$5.00.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.